Cardiac and stroke

Cardiovascular diseases including stroke is the leading cause of death in the world. It accounts for more than 17 million deaths a year and the figure is rising.

Our aim is to develop new strategies for the prevention of cardiovascular diseases by targeting their primary risk factors such as high blood pressure, diabetes, cholesterol and smoking; for the reduction of mobility and disability by improving comprehensive management after onset such as PCI,intravenous alteplase, head position, blood pressure lowering and other physiological cares; and for secondary prevention of cardiovascular diseases.

We conducted a variety of influential cardiovascular diseases research projects, such as Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT), ENhanced Control of Hypertension And Thrombolysis strokE stuDy (ENCHANTED), Head Position in Stroke Trial (HeadPoST) and Sleep Apnea Cardiovascular Endpoints Study (SAVE). Our studies are focused on generating strong evidence to effect real change in practice and policy. By initiating changes in clinical practice and government policy, we hope to reverse the growing impact of these killer diseases. 

Further reading